Last reviewed · How we verify
moderate to severe acute pain
Approved treatments
- Journavx · Vertex Pharms Inc
Journavx blocks sodium channels in the nervous system to reduce pain signal transmission.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- moderate to severe acute pain patent landscape — cliff calendar, originator estates, attackable patents
- moderate to severe acute pain treatment landscape brief
- moderate to severe acute pain treatment updates RSS
Frequently asked questions about moderate to severe acute pain
What drugs treat moderate to severe acute pain?
Tracked treatments include Journavx.
What is the treatment for moderate to severe acute pain?
Standard treatment for moderate to severe acute pain includes Journavx. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: moderate to severe acute pain patent cliff · moderate to severe acute pain CI report
- Treatment: Journavx · Vertex Pharms Inc
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing